Do you want to read an article? Please log in or register.
Serum Biomarkers Identify Patients Who Will Develop Inflammatory Bowel Diseases Up to 5 y Before Diagnosis
Inflammatory Bowel Disease
RECOMMENDED
Related content
Inflammatory Bowel Disease
Effect of distance to specialist care for the diagnosis and disease outcome of inflammatory bowel disease in the Swiss inflammatory bowel disease cohort study
Therap Adv Gastroenterol.
Grob L, Bluemel S, Biedermann L, Fournier N, Rossel JB, Vavricka SR, Zeitz J, Rogler G, Stallmach A, Scharl M
doi: 10.1177/1756284819895217.
Inflammatory Bowel Disease
Inflammatory bowel disease in patients over the age of 70 y. Does the disease duration influence its behavior?
Scand J Gastroenterol.
Huguet JM, Iborra M, Bosca-Watts MM, Maroto N, Gil R, Cortes X, Hervás D, Paredes JM
doi: 10.1080/00365521.
Inflammatory Bowel Disease
Risk of Development of More-advanced Lesions in Patients With Inflammatory Bowel Diseases and Dysplasia
Clin Gastroenterol Hepatol.
Cremer A, Demetter P, De Vos M, Rahier JF, Baert F, Moreels T, Macken E, Louis E, Ferdinande L, Fervaille C, Dedeurwaerdere F, Bletard N, Driessen A, De Hertogh G, Vermeire S, Franchimont D, Belgian Inflammatory Bowel Disease Research and Development (BIRD) Group.
doi: 10.1016/j.cgh.
Inflammatory Bowel Disease
Mortality Associated With Development of Squamous Cell Cancer in Patients With Inflammatory Bowel Disease Receiving Treatment With Thiopurines
Clin Gastroenterol Hepatol.
Khan N, Lee H, Trivedi C, Kavani H, Medvedeva E, Xie D, Lewis JD, Yang YX
doi: 10.1016/j.cgh.2019.03.005.
Inflammatory Bowel Disease
Circulating Leptin Levels as a Potential Biomarker in Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis
Inflamm Bowel Dis.
Carvalho LGF, Lima WG, Coelho LGV, Cardoso VN, Fernandes SOA
doi: 10.1093/ibd/izaa037.
COMMENTED
Inflammatory Bowel Disease
Prevalence and duration of gastrointestinal symptoms before diagnosis of Inflammatory Bowel Disease and predictors of timely specialist review: a population-based study
★ 3
Recommended and commented by
PD Dr Luc Biedermann, Faculty Member
J Crohns Colitis.
Blackwell J, Saxena S, Jayasooriya N, Bottle A, Petersen I, Hotopf M, Alexakis C, Pollok RC, POP-IBD study group.
doi: 10.1093/ecco-jcc/jjaa146.
Inflammatory Bowel Disease
Serum concentrations after switching from originator infliximab to the biosimilar CT-P13 in patients with quiescent inflammatory bowel disease (SECURE): an open-label, multicentre, phase 4 non-inferiority trial
Lancet Gastroenterol Hepatol.
Strik AS, van de Vrie W, Bloemsaat-Minekus JPJ, Nurmohamed M, Bossuyt PJJ, Bodelier A, Rispens T, van Megen YJB, D'Haens GR
doi: 10.1016/S2468-1253
Inflammatory Bowel Disease
Development and validation of a patient-reported score to screen for mucosal inflammation in inflammatory bowel disease
J Crohns Colitis.
de Jong MJ, Roosen D, Degens JHRJ, van den Heuvel TRA, Romberg M, Hameeteman W, Bodelier AGL, Romanko I, Lukas M5, Winkens B, Markus T, Masclee AAM, van Tubergen A, Jonkers DMAE, Pierik MJ
doi: 10.1093/ecco-jcc/jjy196.
Inflammatory Bowel Disease
Illness Perception in Inflammatory Bowel Disease Patients is Different Between Patients With Active Disease or in Remission: A Prospective Cohort Study
doi: 10.1093/ecco-jcc/jjy183.